Private Advisor Group’s Avita Medical RCEL Stock Holding History

Private Advisor Group’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200	Closed	-$6K	–	3004
2020 Q2	$6K	Buy	+200	New	+$6.12K	﹤0.01%	3178

Other funds holding RCEL

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return

Private Advisor Group's RCEL Position: Q3 2020 in Review

Private Advisor Group sold out of Avita Medical (RCEL) in Q3 2020, closing a stake of 200 shares — an estimated $6K sold.

Private Advisor Group first reported a position in RCEL in Q2 2020 and held it in 1 quarter. The position peaked at $6K in Q2 2020. 43 funds tracked by Wall St. Rank hold RCEL as of Q3 2020.

Private Advisor Group reported no remaining Avita Medical position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 200 Avita Medical shares in Q3 2020, an estimated $6K.
Private Advisor Group first reported a position in Avita Medical in Q2 2020 and held it in 1 quarter.
Private Advisor Group's Avita Medical position peaked at $6K in Q2 2020.
43 funds tracked by Wall St. Rank held Avita Medical as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.